Medicine.AI logo Medicine.AI

Introduction

Medicine.AI integrates best‑in‑class AI and computational models in an open, agentic architecture. We orchestrate complex discovery tasks into reliable, reproducible workflows at industrial scale.

Open Architecture

Plug‑and‑play models and data sources; choose fit‑for‑purpose tools.

Agentic Orchestration

Automated planning, reasoning, execution and verification.

Scientific Depth

Insights rivaling cross‑functional teams, delivered at a fraction of cost.

Outcome‑Focused

Actionable candidates and clear go/no‑go decisions.

Explore the Platform

See Medicine.AI From Three Perspectives

Switch between Modality, Use‑Case, and Disease Area views to understand how our agentic system designs, screens, and advances candidates end‑to‑end.

Small Molecules
Design • Enumerate • Screen
Small Molecules

Design, Enumerate, Screen

De novo generation and optimization targeting affinity, selectivity, physicochemical properties, and ADMET — with rapid triage to top candidates.

  • Multi‑objective generative design & filtering
  • Docking, physics‑informed sims, and fast ML scoring
  • ADMET prediction & developability triage
106+ candidates/day Affinity & selectivity Oral/IN/SC routes
Antibody • Peptide • Protein
Design & Engineering
Antibody • Peptide • Protein

Design & Engineering

Motif‑based and scaffold‑centric designs with rigorous developability profiling. Humanization, epitope/affinity engineering, BBB‑aware strategies where required.

  • Structure‑guided & sequence‑based generation
  • Developability: TAP‑style metrics, stability, aggregation
  • Epitope mapping and affinity maturation
Humanization Stability & solubility BBB strategies
Antibody-Drug Conjugates
ADC Design & Effects
Antibody‑Drug Conjugates

ADC Design & Effect Prediction

Precisely tailor antibodies and linkers; optimize DAR, stability, and payload. Predict therapeutic efficacy and by‑stander effects across tissues.

  • Linker/payload selection and DAR tuning
  • Bystander‑effect & toxicity prediction
  • Stability, trafficking, and exposure‑anchored models
Payload libraries Linker chemistries In‑silico efficacy

Our Value Proposition

Our Agentic‑AI drug discovery platform delivers unparalleled speed, scale, and depth of insights, surpassing human expertise and creating transformative impacts.

For Research Institutes and Biotech & Pharmaceutical Companies

Accelerate discovery dramatically—reducing time and cost—while expanding the scientific exploration landscape.

For Biotech & Pharma Investors

Independent, data‑driven analytics and comprehensive metrics enable precise identification and confident evaluation of high‑reward opportunities, minimizing risk.

For Biotech & Pharma Regulators

Immediate, unbiased, and scientifically robust insights into treatment efficacy and safety, reducing reliance on animal testing and mitigating statistical uncertainties inherent in clinical trials.

For Patients and Society

Rapid delivery of effective, affordable, and accessible therapies—saving lives and improving global quality of life.

Why Medicine.AI

Radical Efficiency

Turn slow, manual workflows into continuous, scalable processes.

Accelerated Breakthroughs

Quickly test and advance novel ideas at scale with the best model for the job.

Precise & Reliable Outcomes

Verification loops and transparent reasoning reduce errors, increase reproducibility.

Lower Total Cost

Achieve more with smaller teams and efficient computation—at a fraction of conventional costs.